HIV Treatment with the Two-Drug Regimen Dolutegravir Plus Lamivudine in Real-world Clinical Practice: A Systematic Literature Review

The two-drug regimen dolutegravir plus lamivudine demonstrated durable efficacy for up to 3 years in phase III studies and a high barrier to resistance in treatment-naive and virologically suppressed people with HIV (PWH). This systematic literature review summarizes real-world evidence evaluating e...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Rickesh, Evitt, Lee, Mariolis, Ilias, Di Giambenedetto, Simona, d’Arminio Monforte, Antonella, Casado, José, Cabello Úbeda, Alfonso, Hocqueloux, Laurent, Allavena, Clotilde, Barber, Tristan, Jha, Diwakar, Kumar, Rahul, Kamath, Rahul Dinesh, Vincent, Tia, van Wyk, Jean, Koteff, Justin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572911/
https://www.ncbi.nlm.nih.gov/pubmed/34426899
http://dx.doi.org/10.1007/s40121-021-00522-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8572911/
https://www.ncbi.nlm.nih.gov/pubmed/34426899
http://dx.doi.org/10.1007/s40121-021-00522-7

Ejemplares similares